ArticlePerioperative medicine (London, England)2025
Comparison of midazolam and dexmedetomidine on postoperative delirium in older patients undergoing total knee replacement under spinal anesthesia.
Article in Perioperative medicine (London, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Perioperative interventions in preventing postoperative delirium following orthopaedic surgery in the elderly: a Bayesian network meta-analysis.Journal of orthopaedic translation · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPostoperative delirium (POD) is a frequent and serious complication in older patients undergoing orthopedic surgery. This study aimed to compare the effects of midazolam and dexmedetomidine on the incidence of POD in elderly patients undergoing total knee arthroplasty under spinal anesthesia.
methodsIn this prospective, double-blind, randomized, parallel group comparative trial, a total of 175 patients aged 65 years or older were allocated to receive either midazolam or dexmedetomidine for intraoperative sedation. The primary outcome was the incidence of POD, evaluated using the confusion assessment method for five postoperative days. Secondary outcomes included the quality of sedation, incidence of sedation failure, postoperative analgesic profiles, and complication rates.
resultsThe incidence of POD was significantly lower in the dexmedetomidine group compared to the midazolam group (13.9% vs. 27.4%, P = 0.045). In addition, dexmedetomidine was associated with superior sedation quality and a significantly lower rate of sedation failure (P = 0.007 and P = 0.018, respectively). Postoperative pain intensity and complication rates were comparable between the two groups.
conclusionDexmedetomidine significantly reduced the incidence of POD and improved sedation quality compared to midazolam. These findings suggest that dexmedetomidine may be a preferable sedative for elderly patients undergoing total knee arthroplasty under spinal anesthesia.
trial registrationThis study was registered with the WHO International Clinical Trials Registry Platform (Trial number: KCT0006587, Registration date: 16th September 2021).
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.